Cargando…

IL6 trans-signaling associates with ischemic stroke but not with atrial fibrillation

BACKGROUND: Pro-inflammatory processes underlie ischemic stroke, albeit it is largely unknown if they selectively associate with the risk of atherothrombotic or cardioembolic ischemic stroke. Here we analyze whether pro-inflammatory interleukin (IL) 6 trans-signaling, is associated with the risk of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ziegler, Louise, Wallén, Håkan, Aspberg, Sara, de Faire, Ulf, Gigante, Bruna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351167/
https://www.ncbi.nlm.nih.gov/pubmed/34372806
http://dx.doi.org/10.1186/s12883-021-02321-6
_version_ 1783735913690431488
author Ziegler, Louise
Wallén, Håkan
Aspberg, Sara
de Faire, Ulf
Gigante, Bruna
author_facet Ziegler, Louise
Wallén, Håkan
Aspberg, Sara
de Faire, Ulf
Gigante, Bruna
author_sort Ziegler, Louise
collection PubMed
description BACKGROUND: Pro-inflammatory processes underlie ischemic stroke, albeit it is largely unknown if they selectively associate with the risk of atherothrombotic or cardioembolic ischemic stroke. Here we analyze whether pro-inflammatory interleukin (IL) 6 trans-signaling, is associated with the risk of ischemic stroke and underlying atrial fibrillation (AF). METHODS: During a 20-year follow-up, 203 incident ischemic strokes were recorded from national registers in the cohort of 60-year-old men and women from Stockholm (n = 4232). The risk of ischemic stroke associated with circulating IL6 trans-signaling, assessed by a ratio between the pro-inflammatory binary IL6:sIL6R complex and the inactive ternary IL6:sIL6R:sgp130 complex (B/T ratio), was estimated by Cox regression and expressed as hazard ratio (HR) with a 95% confidence interval (CI) in the presence or absence of AF. Risk estimates were adjusted for cardiovascular risk factors and anticoagulant treatment. In a secondary analysis, the association of IL6 trans-signaling with the risk of incident AF (n = 279) was analyzed. RESULTS: B/T ratio > median was associated with increased risk of ischemic stroke in study participants without AF (adjusted HR 1.49; 95% CI 1.08–2.06), while an association could not be demonstrated in the presence of AF. Moreover, the B/T ratio was not associated with the risk of AF (HR 0.96; 95% CI 0.75–1.24). CONCLUSIONS: Pro-inflammatory IL6 trans-signaling, estimated by the B/T ratio, is associated with ischemic stroke in individuals without AF. These findings suggest that the B/T ratio could be used to assess the risk of non-AF associated ischemic stroke. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12883-021-02321-6.
format Online
Article
Text
id pubmed-8351167
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83511672021-08-09 IL6 trans-signaling associates with ischemic stroke but not with atrial fibrillation Ziegler, Louise Wallén, Håkan Aspberg, Sara de Faire, Ulf Gigante, Bruna BMC Neurol Research BACKGROUND: Pro-inflammatory processes underlie ischemic stroke, albeit it is largely unknown if they selectively associate with the risk of atherothrombotic or cardioembolic ischemic stroke. Here we analyze whether pro-inflammatory interleukin (IL) 6 trans-signaling, is associated with the risk of ischemic stroke and underlying atrial fibrillation (AF). METHODS: During a 20-year follow-up, 203 incident ischemic strokes were recorded from national registers in the cohort of 60-year-old men and women from Stockholm (n = 4232). The risk of ischemic stroke associated with circulating IL6 trans-signaling, assessed by a ratio between the pro-inflammatory binary IL6:sIL6R complex and the inactive ternary IL6:sIL6R:sgp130 complex (B/T ratio), was estimated by Cox regression and expressed as hazard ratio (HR) with a 95% confidence interval (CI) in the presence or absence of AF. Risk estimates were adjusted for cardiovascular risk factors and anticoagulant treatment. In a secondary analysis, the association of IL6 trans-signaling with the risk of incident AF (n = 279) was analyzed. RESULTS: B/T ratio > median was associated with increased risk of ischemic stroke in study participants without AF (adjusted HR 1.49; 95% CI 1.08–2.06), while an association could not be demonstrated in the presence of AF. Moreover, the B/T ratio was not associated with the risk of AF (HR 0.96; 95% CI 0.75–1.24). CONCLUSIONS: Pro-inflammatory IL6 trans-signaling, estimated by the B/T ratio, is associated with ischemic stroke in individuals without AF. These findings suggest that the B/T ratio could be used to assess the risk of non-AF associated ischemic stroke. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12883-021-02321-6. BioMed Central 2021-08-09 /pmc/articles/PMC8351167/ /pubmed/34372806 http://dx.doi.org/10.1186/s12883-021-02321-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ziegler, Louise
Wallén, Håkan
Aspberg, Sara
de Faire, Ulf
Gigante, Bruna
IL6 trans-signaling associates with ischemic stroke but not with atrial fibrillation
title IL6 trans-signaling associates with ischemic stroke but not with atrial fibrillation
title_full IL6 trans-signaling associates with ischemic stroke but not with atrial fibrillation
title_fullStr IL6 trans-signaling associates with ischemic stroke but not with atrial fibrillation
title_full_unstemmed IL6 trans-signaling associates with ischemic stroke but not with atrial fibrillation
title_short IL6 trans-signaling associates with ischemic stroke but not with atrial fibrillation
title_sort il6 trans-signaling associates with ischemic stroke but not with atrial fibrillation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351167/
https://www.ncbi.nlm.nih.gov/pubmed/34372806
http://dx.doi.org/10.1186/s12883-021-02321-6
work_keys_str_mv AT zieglerlouise il6transsignalingassociateswithischemicstrokebutnotwithatrialfibrillation
AT wallenhakan il6transsignalingassociateswithischemicstrokebutnotwithatrialfibrillation
AT aspbergsara il6transsignalingassociateswithischemicstrokebutnotwithatrialfibrillation
AT defaireulf il6transsignalingassociateswithischemicstrokebutnotwithatrialfibrillation
AT gigantebruna il6transsignalingassociateswithischemicstrokebutnotwithatrialfibrillation